Matches in Nanopublications for { ?s ?p "[Despite the low incidence of FGFR2 mutations in ovarian cancer, the two FGFR2 mutations identified in ovarian tumors (S252W, Y376C) overlap with the oncogenic mutations previously identified in endometrial tumors, suggesting activated FGFR2 may contribute to ovarian cancer pathogenesis in a small subset of ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP87689.RA_8DfvlpVhle8FLqBgcd7oItLMcBwvcvhP2nMQhpJfDA130_assertion description "[Despite the low incidence of FGFR2 mutations in ovarian cancer, the two FGFR2 mutations identified in ovarian tumors (S252W, Y376C) overlap with the oncogenic mutations previously identified in endometrial tumors, suggesting activated FGFR2 may contribute to ovarian cancer pathogenesis in a small subset of ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87689.RA_8DfvlpVhle8FLqBgcd7oItLMcBwvcvhP2nMQhpJfDA130_provenance.
- NP593816.RAaE5HzVUnwZfQUMeBi2UonJMeoN0KTVjP_xUan4ikkyo130_assertion description "[Despite the low incidence of FGFR2 mutations in ovarian cancer, the two FGFR2 mutations identified in ovarian tumors (S252W, Y376C) overlap with the oncogenic mutations previously identified in endometrial tumors, suggesting activated FGFR2 may contribute to ovarian cancer pathogenesis in a small subset of ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593816.RAaE5HzVUnwZfQUMeBi2UonJMeoN0KTVjP_xUan4ikkyo130_provenance.
- assertion description "[Despite the low incidence of FGFR2 mutations in ovarian cancer, the two FGFR2 mutations identified in ovarian tumors (S252W, Y376C) overlap with the oncogenic mutations previously identified in endometrial tumors, suggesting activated FGFR2 may contribute to ovarian cancer pathogenesis in a small subset of ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP401824.RABCPOKDuXr7uVf-y1IHopUKWpibV6TdHYpdNOpGAmjIk130_assertion description "[Despite the low incidence of FGFR2 mutations in ovarian cancer, the two FGFR2 mutations identified in ovarian tumors (S252W, Y376C) overlap with the oncogenic mutations previously identified in endometrial tumors, suggesting activated FGFR2 may contribute to ovarian cancer pathogenesis in a small subset of ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401824.RABCPOKDuXr7uVf-y1IHopUKWpibV6TdHYpdNOpGAmjIk130_provenance.
- NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_assertion description "[Despite the low incidence of FGFR2 mutations in ovarian cancer, the two FGFR2 mutations identified in ovarian tumors (S252W, Y376C) overlap with the oncogenic mutations previously identified in endometrial tumors, suggesting activated FGFR2 may contribute to ovarian cancer pathogenesis in a small subset of ovarian tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789867.RASe71tjmFGTFY9Pxa-vO4v_qnhFAsWmAk9IkxEqV-f2w130_provenance.